SAO PAULO, Nov. 4, 2015 /PRNewswire/ -- Ultrapar Participacoes S.A. (BM&FBOVESPA: UGPA3 / NYSE: UGP), a multi-business company engaged in specialized distribution and retail (Ipiranga / Ultragaz / Extrafarma), specialty chemicals (Oxiteno) and storage for liquid bulk (Ultracargo), hereby reports its results for the third quarter of 2015.
Main highlights in 3Q15
- ULTRAPAR'S NET REVENUES TOTAL R$ 19 BILLION IN 3Q15, 11% GROWTH OVER 3Q14.
- ULTRAPAR'S EBITDA REACHES R$ 944 MILLION IN 3Q15, 20% GROWTH OVER 3Q14.
- SHARE REPURCHASE PROGRAM TOTALS 1.9 MILLION SHARES IN 3Q15, REACHING 4.7 MILLION SHARES ACQUIRED IN 9M15.
"During the third quarter, the macroeconomic environment continued to impose challenges, which we could overcome due to consistent investments in resilient segments, to the improvement of processes and to the offering of products and services that suit our customer's needs. Our multi-business positioning allows us to walk through adversity and continue to present sound results and implement our strategic initiatives. We have just opened our first Extrafarma drugstore in an Ipiranga service station, which marks the beginning of a more intense process of cross-fertilization among our specialized distribution and retail businesses."
Thilo Mannhardt – CEO
Results conference call Brazilian conference call/APIMEC November 6th, 2015 09:30 a.m. (US EST) Hotel Unique (Tavarua room) Sao Paulo – SP Telephone for connection: +55 11 2188 0155 Code: Ultrapar
International conference call November 6th, 2015 12:00 p.m. (US EST) Participants in the USA: +1 877 317 6776 Participants in Brazil: 0800 891 0015 International participants: +1 412 317 6776 Code: Ultrapar
Ultrapar Participacoes S.A. UGPA3 = R$ 66.80/share (09/30/15) UGP = US$ 16.72/ADR (09/30/15)
SOURCE Ultrapar Participacoes S.A.